Lung cancer biomarkers based on miRNA

M. Arroyo Varela (Málaga, Spain), E. Espinosa García (Málaga, Spain), E. Salcedo Lobera (Málaga, Spain), R. Larrosa Jiménez (Málaga, Spain), R. Bautista Moreno (Málaga, Spain)

Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Session: Biology of lung cancer: preclinical and translational research
Session type: E-poster
Number: 1132

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Arroyo Varela (Málaga, Spain), E. Espinosa García (Málaga, Spain), E. Salcedo Lobera (Málaga, Spain), R. Larrosa Jiménez (Málaga, Spain), R. Bautista Moreno (Málaga, Spain). Lung cancer biomarkers based on miRNA. 1132

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014

Exploring the 24h-effect of targeted therapies in non-small cell lung cancer from exon array blood profiling using dually constrained correspondence analysis
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015

Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC
Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Year: 2013

Early detection of lung cancer in exhaled breath condensate using miRNA markers
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015


Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level?
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014


Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015

Gene expression profiling reveal novel biomarkers in non-small cell lung cancer
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010

The value of miR221 and miR222 as a biomarker in non small cell lung cancer
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014

Lung microRNAs as biomarkers of post primary TB variants.
Source: International Congress 2019 – Tuberculosis: diagnosis
Year: 2019

Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015


Downregulated anti-angiogenic miR-19a, miR-126 and let-7b in non-small lung cancer have poor but different prognostic values in squamous and adenocarcinoma subtypes
Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Year: 2013



Investigation of survivin gene expression in non small cell lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

Identifying a tissue specific microRNA molecular signature in lung cancer
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021


Association between polymorphisms in microRNA target sites using CLASH data and survival of early-stage non-small cell lung cancer
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017


Lung cancer screening
Source: International Congress 2017 – Chinese Programme 2017
Year: 2017

Lung cancer screening
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

Lung cancer screening
Source: Guideline 2015
Year: 2015

mRNA biomarker screening in pulmonary tumors showing neuroendocrine differentiation
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013


DNA methylation profiling of non-small cell lung cancer reveals an immune signature in COPD patients
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013